Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_assertion description "[Mechanistic studies indicate that the specific phosphoinositide 3-kinase (PI-3K), Akt and mammalian target of rapamycin (mTOR) inhibitors, but not the mitogen-activated protein kinase kinase (MEK) inhibitor, not only abrogate erbB3-mediated upregulation of Survivin, but also reinforce the erbB2/erbB3-coexpressing breast cancer cells to paclitaxel-induced growth inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_assertion evidence source_evidence_literature NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_assertion SIO_000772 20498641 NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_assertion wasDerivedFrom befree-2016 NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_assertion wasGeneratedBy ECO_0000203 NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.
- befree-2016 importedOn "2016-02-19" NP814301.RAdszsJwotAqA-xR2vtyVVOTPqOVGG42ssBKhxx1srdjM130_provenance.